SANTIAGO
MORENO GUILLÉN
Investigador hasta 2007
![Foto de SANTIAGO](/img/nophoto.png)
![Foto de Centro Nacional de Microbiología](/img/noimage_org.png)
Centro Nacional de Microbiología
Majadahonda, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Microbiología (11)
2021
-
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
Journal of Biomedical Science, Vol. 28, Núm. 1
-
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort
Clinical Microbiology and Infection, Vol. 27, Núm. 11, pp. 1678-1684
2020
-
Gender-based vulnerability in women who inject drugs in a harm reduction setting
PLoS ONE, Vol. 15, Núm. 3
2019
-
Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count
Journal of Microbiology, Immunology and Infection, Vol. 52, Núm. 4, pp. 667-671
-
Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients
PLoS ONE, Vol. 14, Núm. 8
2018
2015
-
Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practice
AIDS, Vol. 29, Núm. 16, pp. 2155-2159
-
Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5
-
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5
2012
-
Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonists
AIDS Reviews, Vol. 14, Núm. 3, pp. 208-217
2010
-
Opportunistic infections and organ-specific diseases in HIV-1-infected children: A cohort study (1990-2006)
HIV Medicine, Vol. 11, Núm. 4, pp. 245-252